CHARGE syndrome

What is CHARGE syndrome?

CHARGE syndrome is a rare genetic disorder that affects multiple organ systems during fetal development. The name CHARGE is an acronym representing the most common features: Coloboma (eye defects), Heart defects, Atresia choanae (blocked nasal passages), growth Retardation, Genital and urinary abnormalities, and Ear anomalies including hearing loss. This complex condition occurs in approximately 1 in 8,500 to 10,000 births worldwide. While each person with CHARGE syndrome is affected differently, the combination of sensory impairments—particularly vision and hearing loss—along with other medical complications creates unique challenges that require lifelong, coordinated medical care.

Key statistics

Symptoms

Common features: Coloboma (iris or retinal gaps), congenital heart defects, choanal atresia, hearing loss, balance problems, growth delays, feeding difficulties, intellectual disability, genital abnormalities.

The symptoms of CHARGE syndrome vary significantly between individuals, but several key features help establish the diagnosis. Coloboma affects 80-90% of people with CHARGE syndrome, appearing as a gap or hole in structures of the eye, most commonly the iris, retina, or optic nerve, which can cause vision problems ranging from mild to severe blindness.

Heart defects occur in 75-85% of cases and may include tetralogy of Fallot, atrioventricular canal defects, or other complex congenital heart malformations that often require surgical intervention in infancy.

Submit Your Paper

Choanal atresia—a blockage of the nasal passages—affects about 60% of individuals and can cause severe breathing difficulties in newborns, sometimes requiring emergency intervention.

Ear anomalies are nearly universal, including malformed outer ears, missing or underdeveloped semicircular canals (causing balance problems), and sensorineural hearing loss ranging from mild to profound. The combination of hearing and vision problems creates significant communication challenges.

Growth and developmental delays are common, with many children experiencing feeding difficulties, delayed motor milestones, and intellectual disabilities ranging from mild learning difficulties to severe developmental delays. Genital and urinary abnormalities may include undescended testes, small penis, or kidney malformations.

Causes and risk factors

CHARGE syndrome follows an autosomal dominant inheritance pattern and is caused primarily by mutations in the CHD7 gene, located on chromosome 8. This gene provides instructions for making a protein involved in regulating gene expression during embryonic development. CHD7 mutations account for 90-95% of clinically diagnosed CHARGE syndrome cases.

The vast majority of cases (over 99%) result from de novo mutations, meaning they occur spontaneously and are not inherited from parents. The mutation rate appears to increase with advanced paternal age, though most cases occur in children of parents of all ages. A small percentage of individuals have mutations in the CHD8 or SEMA3E genes, which can cause CHARGE-like features.

There are no known environmental risk factors that cause CHARGE syndrome. The condition occurs randomly during early pregnancy when genetic mutations affect normal embryonic development of multiple organ systems.

Prevention

There is no known way to prevent CHARGE syndrome, as it typically results from spontaneous genetic mutations during early embryonic development. Since most cases are de novo mutations rather than inherited, genetic counseling and carrier testing for parents are generally not applicable.

However, for the rare families where a parent has CHARGE syndrome or carries a CHD7 mutation, genetic counseling is essential. Preimplantation genetic diagnosis (PGD) and prenatal testing through amniocentesis or chorionic villus sampling can be considered for at-risk pregnancies. Prenatal ultrasound may detect some features like heart defects or growth restrictions, though many CHARGE syndrome features are not visible on routine prenatal imaging.

Complications

Without proper medical management, CHARGE syndrome can lead to life-threatening complications. Severe choanal atresia can cause respiratory failure in newborns. Complex heart defects may result in heart failure, poor growth, and developmental delays if not surgically corrected.

The combination of hearing and vision impairments creates significant challenges for communication development and learning. Feeding difficulties and gastroesophageal reflux can lead to failure to thrive, malnutrition, and aspiration pneumonia. Balance problems due to semicircular canal abnormalities affect motor development and increase fall risk throughout life.

Kidney abnormalities may progress to chronic kidney disease. Intellectual disabilities and autism spectrum behaviors can significantly impact educational achievement and social development. Without coordinated care, individuals may experience preventable complications including recurrent infections, delayed development, and reduced quality of life.

Diagnosis

CHARGE syndrome diagnosis relies on clinical criteria established by experts, as no single test is definitive. The major criteria include choanal atresia, characteristic ear abnormalities, and cranial nerve dysfunction (particularly nerves affecting swallowing, facial expression, and hearing). Minor criteria include heart defects, growth deficiency, developmental delays, kidney abnormalities, cleft lip/palate, and distinctive facial features.

Diagnostic testing includes comprehensive ophthalmologic examination to identify colobomas, echocardiography or cardiac catheterization for heart defects, and CT or MRI imaging to evaluate choanal atresia and inner ear structures. High-resolution temporal bone CT scans can reveal semicircular canal abnormalities characteristic of CHARGE syndrome.

Genetic testing for CHD7 mutations confirms the diagnosis in 90-95% of cases meeting clinical criteria. Chromosomal microarray analysis may be performed to rule out other genetic conditions. Comprehensive hearing evaluation, including auditory brainstem response testing, assesses the degree of hearing loss.

Additional testing may include kidney ultrasound, endocrine evaluation for growth hormone deficiency, and swallowing studies to assess aspiration risk.

Treatment

Treatment for CHARGE syndrome requires a multidisciplinary approach addressing each individual’s specific needs. There is no cure, but early intervention and comprehensive medical care significantly improve outcomes.

Surgical interventions often begin in infancy with correction of choanal atresia to establish adequate breathing and repair of congenital heart defects. Multiple surgeries may be needed throughout childhood for heart complications, ear reconstruction, or eye procedures to address colobomas.

Hearing management includes hearing aids, bone-anchored hearing aids, or cochlear implants depending on the type and severity of hearing loss. Early amplification is crucial for speech and language development.

Growth hormone therapy may be prescribed for children with documented growth hormone deficiency. Feeding support often requires gastrostomy tube placement for adequate nutrition and medication administration.

Supportive therapies include physical therapy for balance and motor delays, occupational therapy for daily living skills, and speech-language therapy addressing communication challenges. Vision services help maximize remaining vision and teach adaptive techniques.

Medications may include furosemide for heart failure management and omeprazole for gastroesophageal reflux. Hormone replacement therapy may be needed during puberty for individuals with genital abnormalities.

Prognosis

The prognosis for CHARGE syndrome varies significantly depending on the severity of heart defects and the degree of developmental delays. With modern medical care, many individuals survive to adulthood and can achieve meaningful levels of independence.

Survival rates have improved dramatically with advances in cardiac surgery and neonatal care. However, individuals with severe heart defects or multiple life-threatening complications may face reduced life expectancy. The combination of sensory impairments presents ongoing challenges, but early intervention and appropriate support services can lead to significant developmental progress.

Many adults with CHARGE syndrome live semi-independently, maintain employment in supported settings, and develop meaningful relationships. Educational outcomes vary widely, with some individuals attending mainstream schools with support while others require specialized educational programs. The key prognostic factors include severity of heart disease, degree of intellectual disability, and access to comprehensive early intervention services.

Quality of life

Living with CHARGE syndrome requires ongoing adaptations, but many individuals and families report good quality of life with appropriate support systems. Daily routines often involve managing multiple medical appointments, medications, and assistive devices for hearing and vision.

Communication adaptations may include sign language, visual cues, tactile communication, or assistive technology depending on the individual’s sensory abilities. Many families become fluent in multiple communication methods.

Educational and vocational support helps individuals reach their potential. Special education services, vocational rehabilitation, and supported employment programs enable many adults with CHARGE syndrome to work in community settings.

Physical activity should be encouraged within medical limitations. Balance issues may require modifications, but adaptive sports and recreational activities promote physical health and social connections. Regular medical monitoring helps prevent complications and maintains optimal health.

Mental health support is important, as individuals with CHARGE syndrome may experience higher rates of anxiety and depression related to medical complications and communication challenges.

Pregnancy and fertility

Fertility in CHARGE syndrome varies depending on the specific genital and urinary abnormalities present. Males may have undescended testes, small penis, or hypogonadotropic hypogonadism requiring hormone therapy for sexual development and fertility. Females may have normal fertility or may experience delays in puberty requiring hormonal support.

For individuals with CHARGE syndrome who can conceive, genetic counseling is essential since the condition follows autosomal dominant inheritance. Each child has a 50% chance of inheriting the condition. Prenatal testing options should be discussed with a genetic counselor and maternal-fetal medicine specialist.

Pregnancy management requires careful coordination between obstetric and specialty care providers, particularly for women with underlying heart defects or kidney abnormalities that may affect pregnancy tolerance.

Children

Children with CHARGE syndrome require intensive early intervention services beginning in infancy. Early identification and management of hearing loss through amplification or cochlear implants is crucial for language development. Vision services help maximize remaining sight and teach adaptive skills.

Educational planning should begin early, with many children benefiting from specialized programs for children with combined vision and hearing loss (deafblind education). Individualized Education Programs (IEPs) should address communication needs, academic goals, and life skills development.

Feeding difficulties are common in infancy and may require occupational therapy, modified feeding techniques, or gastrostomy tube placement. Growth monitoring and nutritional support help optimize development. Regular developmental assessments guide therapy interventions and educational planning.

Social skills development may require specific support due to communication challenges and developmental delays. Many children benefit from interaction with other children who have similar communication needs.

When to see a doctor

Emergency situations requiring immediate medical attention include severe breathing difficulties, signs of heart failure (increased fatigue, difficulty feeding, rapid breathing), or significant changes in consciousness or responsiveness.

Urgent care is needed for persistent vomiting, signs of dehydration, severe respiratory infections, or significant changes in hearing or vision function.

Routine follow-up should include regular cardiology visits (frequency depending on heart defect severity), annual hearing evaluations, ophthalmology examinations, growth and nutrition monitoring, and developmental assessments. Adults should maintain regular primary care with providers familiar with CHARGE syndrome complications.

Parents and caregivers should be educated about signs of complications specific to their child’s medical issues and have clear emergency plans for managing acute problems.

Regional context

Limited data exists on CHARGE syndrome prevalence specifically within the Caucasus region (Georgia, Armenia, Azerbaijan) and Eastern Mediterranean countries. The condition likely occurs at similar rates to global estimates of 1 in 8,500-10,000 births, but regional genetic studies would help confirm this.

Access to specialized services for individuals with CHARGE syndrome may vary significantly across the region. Genetic testing availability, cochlear implant programs, and specialized educational services for children with combined vision and hearing loss may be limited in some areas.

The Global Medical Journal welcomes contributions from healthcare providers and researchers in the Caucasus and Eastern Mediterranean regions regarding their experiences with CHARGE syndrome diagnosis, management, and outcomes to better understand regional patterns and healthcare needs.

Research and clinical trials

Current research focuses on better understanding CHD7 gene function and developing targeted therapies. Studies are investigating the molecular mechanisms underlying CHARGE syndrome to identify potential therapeutic targets.

Clinical trials may be available through ClinicalTrials.gov for various aspects of CHARGE syndrome management, including hearing restoration research, growth hormone studies, and behavioral interventions. Cochlear implant outcome studies specifically in CHARGE syndrome populations are ongoing.

Recent advances include improved surgical techniques for choanal atresia repair, better understanding of CHD7 gene function, and development of standardized assessment tools for individuals with combined vision and hearing loss. Research into gene therapy approaches is in early stages.

International collaborative research efforts are working to establish better outcome measures and treatment protocols for this rare condition.

Frequently asked questions

What does the acronym CHARGE stand for?

CHARGE represents the major features: Coloboma (eye defects), Heart defects, Atresia choanae (blocked nasal passages), growth Retardation, Genital and urinary abnormalities, and Ear anomalies. Not every person has all features.

Is CHARGE syndrome inherited from parents?

Over 99% of cases result from new (de novo) genetic mutations and are not inherited from parents. However, the condition can be passed to children, with each child having a 50% chance of inheriting it.

Can children with CHARGE syndrome learn to communicate?

Yes, with appropriate support and early intervention. Communication methods may include speech, sign language, tactile communication, or assistive technology, depending on the individual’s hearing and vision abilities.

What is the life expectancy for someone with CHARGE syndrome?

Life expectancy varies significantly based on the severity of heart defects and other complications. With modern medical care, many individuals survive to adulthood and can live relatively normal lifespans with appropriate medical management.

Can women with CHARGE syndrome have children safely?

Many women with CHARGE syndrome can have successful pregnancies, though this depends on their specific medical complications, particularly heart and kidney function. Close monitoring by specialists is essential throughout pregnancy.

Support and resources

International organizations:

• CHARGE Syndrome Foundation – Primary support organization with resources for families and professionals
• Orphanet – European database of rare diseases and orphan drugs
• National Organization for Rare Disorders (NORD) – Patient advocacy and support
• EURORDIS – European rare disease patient advocacy alliance
• World Health Organization – Rare Diseases – Global health perspectives

Related conditions

• 22q11.2 deletion syndrome – Another genetic syndrome with heart defects and developmental delays
• Usher syndrome – Genetic condition causing combined hearing and vision loss
• Goldenhar syndrome – Condition affecting ear development and facial features
• VATER association – Multiple congenital anomalies with some overlapping features
• Kabuki syndrome – Genetic disorder with developmental delays and distinctive features

Sources: Orpha

Licensed under CC BY 4.0. Free to share with attribution to GMJ News.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.